Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pulmonary Fibrosis Article
This is a selection made from among articles on Drug Treatment Pulmonary Fibrosis. For a permanent link to this article, or to bookmark it for future reading, click here.
Causes of Drug Addiction
from:Why do some people choose to use drugs when they’re so bad for you? The causes of drug addiction are as varied as the amount of drugs that are available for use – both legally and illegally. There is no one cause for drug addiction just like there is no consistent profile of a drug user.
People who have a history of drug use or abuse in their families are at risk for drug addiction problems. It has been proven that children of alcoholics will exhibit addictive tendencies. Children of alcoholics or drug users generally have low self-esteem and see their parents escaping from problems using drugs. When they see this, their minds say that this is the way to act and they themselves become users.
There is also a biological basis for causing drug addiction. Drugs alter the brain’s chemicals and the way the brain functions. Drug addiction creates dependence in the brain by changing the brain’s reward functions – the part that reinforces certain behaviors.
Prescription drug addiction is caused by the person’s inability to function without the drug in their system. People become addicted to prescription drugs because they usually are taking them to overcome some type of pain. They begin to feel that if they are not taking their pills, the pain will return.
Some people are more prone to addiction than others. People who have low self-esteem, are often depressed, and who feel they have no control over their lives will often turn to drugs as a way to cope. They often feel they can’t please the people around them so they have to change themselves in order to fit in. The change is made easier by using drugs because the drugs transform them into someone and something that they are not.
Stress is often attributed as a cause of drug addiction. Life can be very stressful no matter who you are. Some of us are better able to cope with stress than others. Others still just look for an easy way to forget their stress – and that easy way is through drugs. Once the drug use starts, it’s often difficult to get away from it because the stresses will still be there once the high is gone, so the user feels he or she needs more drugs to cope. That type of cycle leads to addiction.
Finally, drugs are easily accessible. They are available in many places if you just ask around for them. Because of that easy access, it’s more likely that a person will begin using eventually becoming addicted.
The causes of drug addiction are wide and varied. The key to stopping drug addiction is to get rid of those causes before they become a problem.
Drug Treatment Pulmonary Fibrosis Specific links
Drug Treatment Pulmonary Fibrosis News
Pulmonary Fibrosis Cocktail Dangerous - Drug Discovery & Development
Pulmonary Fibrosis Cocktail Dangerous Drug Discovery & Development A combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis, according to ... |
InterMune deal delivers $55M in fresh fuel for fibrosis drug - FierceBiotech
InterMune deal delivers $55M in fresh fuel for fibrosis drug FierceBiotech The money is being used to fuel the launch of pirfenidone (Esbriet) in Europe, a new treatment for idiopathic pulmonary fibrosis. The FDA, though, rejected the drug in 2010, forcing InterMune to mount a new late-stage study as the company remained ... |
Combo Treatment for IPF Deadly - MedPage Today
Combo Treatment for IPF Deadly MedPage Today Point out that the study was terminated due to increased risk of death and hospitalization in those treated with combination therapy compared with placebo. SAN FRANCISCO – A widely used combination treatment for idiopathic pulmonary fibrosis increased ... Danger in standard lung disease treatment |
Stopping cell migration may help block fibrosis and the spread of cancer - Medical Xpress
Stopping cell migration may help block fibrosis and the spread of cancer Medical Xpress The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration. Blocking cell migration |
Stopping cell migration may help block fibrosis and the spread of cancer - Bizcommunity.com
Stopping cell migration may help block fibrosis and the spread of cancer Bizcommunity.com The researchers have both uncovered a signaling pathway that promotes cell migration in certain forms of pulmonary fibrosis, a deadly lung disease, and developed a drug treatment that may block the cancer cell migration. |
Stony Brook, NYU in deal with drug firm - Chicago Tribune
Stony Brook, NYU in deal with drug firm Chicago Tribune It calls for the New Brunswick, NJ, company to work with researchers from the schools on an inhalable treatment for the condition, idiopathic pulmonary fibrosis. The disease affects about 200000 Americans each year. It's caused by scar tissue in the ... |
Late-breaking clinical trials - EurekAlert (press release)
Late-breaking clinical trials EurekAlert (press release) These studies examine treatments for ventilator-associated pneumonia, cardiac surgery associated kidney injury, septic shock, idiopathic pulmonary fibrosis, smoking cessation, malignant pleural effusion and non-cystic fibrosis bronchiectasis. |
Vertex finds key support for cystic fibrosis drug in Europe - FierceBiotech
 Proactive Investors USA & Canada | Vertex finds key support for cystic fibrosis drug in Europe FierceBiotech Vertex ($VRTX) has taken another step toward building a global franchise for treating cystic fibrosis. European regulatory advisers backed approval of the trailblazing drug Kalydeco for a subset of patients with the genetic disorder, paving the way for ... Vertex Pharma receives European recommendation for approval of cystic fibrosis ... |
InterMune agrees to sell immune drug Actimmune - BusinessWeek
InterMune agrees to sell immune drug Actimmune BusinessWeek Esbriet is designed to treat a terminal lung disease called idiopathic pulmonary fibrosis. IPF causes inflammation and scarring of the lung, making it harder for patients to breathe. InterMune started selling the drug in Germany in September and is ... InterMune sells Actimmune to Vidara to concentrate on Esbriet |
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... - MarketWatch (press release)
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... MarketWatch (press release) "While there has been great progress in cystic fibrosis treatment during the last few decades, we are still only treating the symptoms and complications of the disease," said Stuart Elborn, MD, KALYDECO investigator and President of the European Cystic ... |